HaemaLogiX Shines at APAC CGT Excellence Awards with CAR-T Innovation HaemaLogiX Ltd has been awarded the 'Most Promising CAR-T Pipeline' at the 2025 Asia Pacific CGT Excellence Awards, honoring its pioneering immunotherapies.

HaemaLogiX Shines at APAC CGT Excellence Awards with CAR-T Innovation #Australia #Sydney #CAR-T_therapy #Multiple_Myeloma #HaemaLogiX

HaemaLogiX Honored for Promising CAR-T Pipeline in Asia Pacific HaemaLogiX Ltd, a leading Australian biotech firm, has been recognized with the prestigious 'Most Promising CAR-T Pipeline' award at the Asia Pacific CGT Excellence Awards 2025, held in Singapore.

HaemaLogiX Honored for Promising CAR-T Pipeline in Asia Pacific #Australia #Sydney #CAR-T_therapy #Multiple_Myeloma #HaemaLogiX